<?xml version="1.0" encoding="UTF-8"?>
<p>Alpha-glucosidase inhibitors are a class of oral glucose lowering drugs which act by inhibiting enzymes of the intestinal epithelial lining involved in the digestion of complex sugars into smaller, easily absorbed monosaccharides [
 <xref rid="B30-jof-07-00058" ref-type="bibr">30</xref>]. They can be used alone or in combination therapy, notably to reduce postprandial blood glucose levels contributed by carbohydrates. However, by preventing complex carbohydrate digestion thus leaving some undigested carbohydrates, which are digested by colonic bacteria, alpha-glucosidase inhibitors exhibit dose-dependent gastrointestinal side-effects such as flatulence and diarrhea that can limit their use [
 <xref rid="B30-jof-07-00058" ref-type="bibr">30</xref>].
</p>
